An overexpression of B promotes breast tumour cell proliferation and invasion (59, 60), whilst levels of FnIIIC+ variants positively correlate with disease duration and degree of joint erosion and negatively correlate with response to anti-TNF biologic therapy (16). Here, TNF is linked to breast neoplasm.